These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19212305)

  • 1. The management of hepatitis C.
    Pan JJ; Firpi RJ
    Minerva Gastroenterol Dietol; 2009 Mar; 55(1):23-35. PubMed ID: 19212305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boceprevir, an NS3 protease inhibitor of HCV.
    Berman K; Kwo PY
    Clin Liver Dis; 2009 Aug; 13(3):429-39. PubMed ID: 19628159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular methods of hepatitis C genotyping.
    Weck K
    Expert Rev Mol Diagn; 2005 Jul; 5(4):507-20. PubMed ID: 16013969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and vaccination for hepatitis C: present and future.
    Jawaid A; Khuwaja AK
    J Ayub Med Coll Abbottabad; 2008; 20(1):129-33. PubMed ID: 19024206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim results presented at EASL from PROVE 1 clinical trial of investigational drug telaprevir in patients with genotype 1 hepatitis C.
    Lang L
    Gastroenterology; 2007 Jun; 132(7):2283-4. PubMed ID: 17570199
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis C: epidemiology and review of complementary/alternative medicine treatments.
    Patrick L
    Altern Med Rev; 1999 Aug; 4(4):220-38. PubMed ID: 10468647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and future hepatitis C therapies.
    Firpi RJ; Nelson DR
    Arch Med Res; 2007 Aug; 38(6):678-90. PubMed ID: 17613359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance mechanisms in HCV: from evolution to intervention.
    Kim AY; Timm J
    Expert Rev Anti Infect Ther; 2008 Aug; 6(4):463-78. PubMed ID: 18662114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tailored treatment for hepatitis C.
    Berg T
    Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection.
    Hsu CS; Liu CH; Liu CJ; Wang CC; Chen CL; Lai MY; Chen PJ; Chen DS; Kao JH
    Am J Gastroenterol; 2009 Mar; 104(3):598-604. PubMed ID: 19262519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The way forward in HCV treatment--finding the right path.
    Manns MP; Foster GR; Rockstroh JK; Zeuzem S; Zoulim F; Houghton M
    Nat Rev Drug Discov; 2007 Dec; 6(12):991-1000. PubMed ID: 18049473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C and diabetes: the inevitable coincidence?
    Lonardo A; Adinolfi LE; Petta S; Craxì A; Loria P
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):293-308. PubMed ID: 19344243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-based therapy for chronic hepatitis C.
    Chang DY; Shin EC
    J Leukoc Biol; 2009 Jul; 86(1):33-9. PubMed ID: 19395471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and molecular biology of HCV infection and hepatitis.
    Tang H; Grisé H
    Clin Sci (Lond); 2009 Jun; 117(2):49-65. PubMed ID: 19515018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent contributions of in vitro models to our understanding of hepatitis C virus life cycle.
    Régeard M; Lepère C; Trotard M; Gripon P; Le Seyec J
    FEBS J; 2007 Sep; 274(18):4705-18. PubMed ID: 17824957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C in children: recent advances.
    Zein NN
    Curr Opin Pediatr; 2007 Oct; 19(5):570-4. PubMed ID: 17885477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.